Autoimmune Disease Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts to 2027
Autoimmune
Disease Treatment Market Research Information: By Disease Type (Localized,
Systemic), Diagnosis (Elisa, Dot Blot, Agglutination, Others), Therapeutic
Products (Drugs, Monitoring Equipment), Distribution Channel – Global Forecast
Till 2027
Autoimmune Disease
Treatment Market Highlights
The global autoimmune
disease treatment market is expected to grow at a CAGR of 11.2%
over the forecast period, according to the latest research report from Market
Research Future (MRFR). The global autoimmune disease treatment market is
mainly driven by the growing prevalence of autoimmune diseases, the growing
awareness about autoimmune disease treatment, and the growing development of a
number of effective treatments for autoimmune diseases based on modern medical
processes such as genomics.
Autoimmune diseases are
diseases caused by the immune system mistaking the body’s own tissue for
foreign tissues and attacking it. This can happen due to a number of
complications within the immune system and can have disastrous consequences on
the health of the individual. Some of the most widely prevalent autoimmune
diseases include rheumatoid arthritis, lupus, and multiple sclerosis. Growing
awareness about autoimmune diseases and their treatment is likely to be a major
driver for the global autoimmune disease treatment market over the forecast
period. While autoimmune diseases have always been present among human populations,
their sporadic appearance and lack of infectiousness made them relatively minor
subjects of study compared to other, more imminent threats. The growing
prevalence of autoimmune diseases in modern times has led to growing awareness
about the disease and is likely to remain the key driver for the autoimmune
disease treatment market over the forecast period.
Growing development of
effective treatments for a number of autoimmune diseases is likely to be a
major driver for the global autoimmune disease treatment market over the
forecast period. Autoimmune diseases can be hard to treat effectively, as
treating them effectively means shutting down or slowing down the operations of
the body’s immune system. While this may be an effective way of combating autoimmune
diseases, this can also leave the body vulnerable to other infections and
diseases that can make the most of the body’s temporary weakness. The use of
genetic components in treating autoimmune diseases is a new aspect gained by
the autoimmune disease treatment market in the last few years and is likely to
remain a key part of the market over the forecast period due to the increasing
awareness about its effectiveness and safety.
Request Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/5586
Competitive Analysis:
Leading players in the global
autoimmune disease treatment market include Abbott Laboratories, Genentech
Inc., Biogen Idec Inc., Chugai Pharmaceutical Co. Ltd., Elan Corporation plc,
F. Hoffman-La Roche AG, HYCOR Biomedical, Merck & Co. Inc., Squibb Company,
Thermo Fisher Scientific, Siemens, Johnson & Johnson Inc., GlaxoSmithKline
plc, Eli Lilly and Company, Danaher, Bio-Rad, Bayer Schering Pharma AG, and
Amgen Inc.
Industry Updates:
Researchers at the University
of Virginia School of Medicine, working in collaboration with Inova Health,
discovered in February 2019 that deleting a gene called ELMO1 reduces the
severity of arthritis in mice. Such discoveries could prove crucial for the
global autoimmune disease treatment market over the forecast period, as the
genetic background of autoimmune diseases is likely to take on an important
role due to the growing understanding and awareness about genetics and its
application in disease treatment.
Segmentation:
The global autoimmune disease
treatment market is segmented on the basis of disease type, diagnosis,
therapeutic products, distribution channels, and region.
On the basis of the disease
type, the market is classified into localized diseases and systemic diseases.
The localized segment is further classified into multiple sclerosis,
inflammatory bowel disease, diabetes, and others, whereasthe systemic segment
is segmented into rheumatoid arthritis, psoriasis, lupus, and others.
On the basis of diagnosis, the
autoimmune disease treatment market is classified as ELISA, dot blot, line
blot, agglutination, double immune diffusion, western blotting, multiplex
immunoassay, and others.
On the basis of the therapeutic
product, the autoimmune disease treatment market is segmented into drugs and
therapeutic & monitoring equipment. The drugs segment is further segmented
into biologics, immunosuppressants, anti-inflammatory drugs, corticosteroids,
and non-steroidal anti-inflammatory drugs.
On the basis of the
distribution channel, the autoimmune disease treatment market is segmented into
hospitals & clinics, diagnostic centers, drug stores, pharmacies, and
others.
Regional Analysis:
The Americas are likely to
remain the leading revenue generator in the global autoimmune disease treatment
market over the forecast period due to the growing economic burden of
autoimmune diseases and the rapid growth of the healthcare sector to equip
itself with modern methodologies to deal with autoimmune diseases. Europe holds
the second largest share in the global autoimmune disease treatment market and
is likely to remain a sizeable contender over the forecast period due to the
growing government support to advances in the healthcare sector.
Browse Detailed TOC with
COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/autoimmune-disease-treatment-market-5586
About
Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email:
sales@marketresearchfuture.com
Comments
Post a Comment